Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Shockeron Jan 08, 2023 12:23pm
170 Views
Post# 35209670

RE:Att: Navajoe

RE:Att: NavajoeNDA agreement in what they can say and not. Why would an NDA allow them to use the word of the name of the company as well use Sirona will be self supporting unless the Abbvie is not the deal directed towrds. 

No I never looked at the 60 cents as being a number sustainable. But i did think the 40s wa stable.

What has cause it to have a medium level of 40 to 11 cents should be a concern. As if this was close to be close we would not be at 11 cents. As management would use stronger words range of dates. It also scare me , what really does a NDA represent ? 

In my thoughts and could be wrong they dont have a firm contract drafted or else they would use such terms such as the next 30 to 45 and that would be a range. It scares me the use of NDA is used ....

Navjoe is spot on his lack of trust and endless talks that have not been rewarding to the most important part of a public stock shareholder .........

Management seems salaries paid they are ok regardless of shareholders rewards. Well paid management  should bring results lets see of different 2023 to 2022, 20021, 2020, 2019 ETC Etc Etc Etc 


<< Previous
Bullboard Posts
Next >>